choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Synagis

Synagis Newsletter
  • Rising Prevalence Of Chronic Respiratory Conditions Driving The Market : Key Driver Transforming the Synagis Market 2025 06 Feb 2025 17:56 GMT

    … for personalized medicine and telehealth, development of RSV treatments, a growing … preferences, and environmental pollution. Synagis, scientifically known as palivizumab, helps … Synagis market. Leaders in the industry are concentrating on securing drug …

  • Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trial 30 Jan 2025 18:57 GMT

    … The S-337395 treatment group showed a statistically … the US Food and Drug Administration (FDA) in October 2024 … Trials Arena. Elsewhere in the RSV space, US company Blue Lake Biotechnology … /IIa trial. Meanwhile, Enanta Pharmaceuticals has reported positive …

  • Additional Reporting of 2025 Prescription Drug Price Changes 10 Jan 2025 18:12 GMT

    … increase) · AstraZeneca (NYSE: AZN): SYNAGIS (6.5% increase) · Seqirus: … particularly in preparation for Medicare drug price negotiations. Please note … , with global clients including biotech, pharmaceuticals, government agencies, consultancies, academia …

  • Weekend Doctor: New treatments protect babies from RSV 04 Jan 2025 11:15 GMT

    … a monoclonal antibody, much like Synagis, which protects the baby from … vaccine. Rather, this is a medication that introduces the antibiotics to …

  • Govt funding expands pharmac medicine access 01 Jan 2025 18:09 GMT

    … four years to enhance medicine availability. “Pharmac operates … in negotiating deals with pharmaceutical companies, ensuring the … who have previously undergone treatment. HER2-positive metastatic … funding of Palivizumab (Synagis) offers relief by preventing …

  • New Year, New Medicines 31 Dec 2024 20:13 GMT

    … facilitate access to new treatments. “Pharmac continues to … people who have received other treatments previously. “Patients with … ). “Palivizumab (branded as Synagis) will also be funded … for deciding which medicines and medical devices are funded …

  • FDA Accepts Biologics License Application for Clesrovimab to Protect Infants from RSV Infection 19 Dec 2024 19:11 GMT

    … efficacy of clesrovimab versus palivizumab (Synagis; Swedish Orphan Biovitrum AB). … phase 2b/2 trial demonstrated that clesrovimab reduced RSV … authors noted that the trial met both the secondary … points.3 The FDA set a prescription drug user fee act …

  • Merck targets 2025 RSV season with antibody now under FDA review 17 Dec 2024 17:12 GMT

    Dive Brief: Doctors could have a new treatment option for protecting newborn … to launch the antibody medicine ahead of the typical … responses across age groups and trials. Merck’s application for … 3 study comparing the drug to Synagis in infants with increased …

  • New RSV drug for babies is over 90% effective at preventing hospitalization 09 Dec 2024 22:17 GMT

    … nirsevimab (Beyfortus), a drug approved in 2023. The medicine, which is given … medical centers, and they needed different levels of care, ranging from outpatient doctor … the new drug, while 16 got an older drug called palivizumab (Synagis) that…

  • Cancer patient's relief after restrictions removed for 'incredible' new drug 07 Dec 2024 08:37 GMT

    … she had previously tried the treatment called Kadcyla (also called … drug," she said. "Rarely have we seen doctors … a new medicine." Pharmac's director of pharmaceuticals Geraldine … cancer Palivizumab (branded as Synagis) to prevent RSV in …

Satisfied with the content?

Continue to create your account.